| 发明名称 |
Fused-ring compounds and use thereof as drugs |
| 摘要 |
A fused ring compound of the formula (I) wherein each symbol is as defined in the specification, a pharmaceutically acceptable salt thereof, and a therapeutic agent for hepatitis C, which contains this compound. The compound shows an anti-hepatitis C virus (HCV) action based on the HCV polymerase inhibitory activity, and is useful as a therapeutic agent or prophylactic agent for hepatitis C. |
| 申请公布号 |
NZ514403(A) |
申请公布日期 |
2002.10.25 |
| 申请号 |
NZ20000514403 |
申请日期 |
2000.12.22 |
| 申请人 |
JAPAN TOBACCO INC |
发明人 |
HASHIMOTO, HIROMASA;MIZUTANI, KENJI;YOSHIDA, ATSUHITO |
| 分类号 |
A61K31/4184;A61K31/42;A61K31/427;A61K31/437;A61K31/4439;A61K31/4523;A61K31/496;A61K31/519;A61K31/52;A61K31/53;A61K31/55;A61K31/7076;A61P1/16;A61P31/20;C07D235/18;C07D235/30;C07D401/04;C07D401/10;C07D401/12;C07D401/14;C07D403/04;C07D403/12;C07D405/04;C07D405/12;C07D409/04;C07D409/12;C07D409/14;C07D413/04;C07D413/12;C07D417/12;C07D495/04;C07D521/00;(IPC1-7):C07D209/12;A61K31/541;A61K31/537;A61K31/506;A61K31/498;A61K31/472;A61K31/470;A61K31/454;A61K31/443;A61K31/433;A61K31/428;A61K31/422;A61K31/418;A61K31/417;A61K31/407;C07D487/04;C07D471/04 |
主分类号 |
A61K31/4184 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
